Maternal and Child Health Practice Questions

Q: Maternal mortality rate is calculated based on deaths occurring up to what period after delivery?

42 days after delivery. **Explanation:** The correct answer is **42 days after delivery (Option B)**. This definition is standardized by the World Health Organization (WHO) and the International Classification of Diseases (ICD). **Why it is correct:** A maternal death is defined as the death of a woman while pregnant or within **42 days (6 weeks)** of termination of pregnancy, irrespective of the duration and site of the pregnancy. This period corresponds to the **puerperium**, during which the body undergoes physiological reversal to the non-pregnant state. Deaths included must be from any cause related to or aggravated by the pregnancy or its management, but not from accidental or incidental causes. **Why other options are incorrect:** * **Option A (Immediately):** This would only account for intrapartum deaths (e.g., amniotic fluid embolism or acute hemorrhage), missing the majority of postpartum complications like sepsis or secondary PPH. * **Option C (7 days):** This represents the "early neonatal period" for infants, but for mothers, many life-threatening complications (like puerperal sepsis) often manifest after the first week. * **Option D (21 days):** This is an arbitrary timeframe with no clinical or statistical significance in maternal health monitoring. **High-Yield NEET-PG Pearls:** * **Maternal Mortality Ratio (MMR):** Calculated per **100,000 live births**. It measures the obstetric risk. (Note: It is a *ratio*, not a true *rate*). * **Maternal Mortality Rate:** Calculated per 1,000 women of reproductive age (15-49 years). * **Late Maternal Death:** Death occurring more than 42 days but less than **one year** after termination of pregnancy. * **Most common cause of Maternal Mortality in India:** Obstetric Hemorrhage (specifically Postpartum Hemorrhage/PPH). * **SDG Target 3.1:** Reduce the global MMR to less than **70 per 100,000 live births** by 2030.

Q: What is the ideal number of antenatal visits recommended?

4. The correct answer is **A (4)**. ### **Explanation** The "Ideal" number of antenatal visits is a frequently tested concept in NEET-PG, often leading to confusion between WHO and National guidelines. 1. **Why Option A is Correct:** According to the **WHO (Focussed Antenatal Care model)** and the **Ministry of Health and Family Welfare (MoHFW), India**, the minimum recommended number of antenatal visits for a healthy pregnant woman is **4**. These are scheduled as follows: * **1st Visit:** Within 12 weeks (Registration/First trimester). * **2nd Visit:** Between 14–26 weeks (Second trimester). * **3rd Visit:** Between 28–34 weeks (Third trimester). * **4th Visit:** Between 36 weeks and term. 2. **Why Other Options are Incorrect:** * **Option B (8):** In 2016, the WHO updated its "Antenatal Care Model" to recommend a minimum of **8 contacts** to reduce perinatal mortality. However, in the context of standard Indian guidelines and traditional NEET-PG questions, **4** remains the "ideal minimum" unless "WHO 2016 guidelines" are specifically mentioned. * **Options C & D:** These do not correspond to any standard global or national protocol for routine antenatal care. ### **High-Yield Clinical Pearls for NEET-PG** * **Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA):** Conducted on the **9th of every month** to ensure at least one check-up by a specialist. * **Weight Gain:** Average weight gain during pregnancy is **11 kg**. * **Tetanus Prophylaxis:** Two doses of Td (Tetanus-diphtheria) are given; the first at registration and the second 4 weeks later. If the woman was immunized within the last 3 years, only one **booster dose** is required. * **Iron-Folic Acid (IFA):** 100mg elemental iron and 500mcg folic acid for 180 days (starting from the second trimester).

Q: ASHA workers are not depot holders of which of the following?

Oral Polio Vaccine (OPV). **Explanation:** The core concept behind this question is the **Cold Chain requirement**. ASHA (Accredited Social Health Activist) workers are community-based volunteers who act as "depot holders" for essential health commodities that can be stored at room temperature. **Why Oral Polio Vaccine (OPV) is the correct answer:** OPV is highly heat-sensitive and must be maintained in a strict cold chain (stored at +2°C to +8°C at the PHC level and -20°C at the district level). ASHA workers do not possess the infrastructure (like ILRs or deep freezers) to maintain this cold chain. Therefore, vaccines are never "stocked" by ASHAs; they are only transported in vaccine carriers during immunization days (RI/Pulse Polio). **Analysis of incorrect options:** * **ORS & IFA Tablets:** These are essential life-saving commodities for managing diarrhea and anemia, respectively. They are stable at room temperature and are part of the standard **ASHA Drug Kit** to ensure immediate community access. * **Contraceptives:** ASHAs are primary providers for the "Home Delivery of Contraceptives" scheme. They hold stocks of condoms, Oral Contraceptive Pills (Mala-N), and Emergency Contraceptive Pills (ECP) to promote family planning. **High-Yield Clinical Pearls for NEET-PG:** * **ASHA Kit Contents:** Includes ORS, IFA (Large & Small), Chloroquine, Paracetamol, DDK (Disposable Delivery Kits), and Contraceptives. * **New Additions:** ASHAs are now also depot holders for **Pregnancy Test Kits (Nishchay)** and **Rapid Diagnostic Kits (RDK)** for Malaria. * **Population Norm:** 1 ASHA per 1,000 population (Plain areas) and 1 per habitation (Tribal/Hilly areas). * **Incentive:** ASHAs are not salaried but receive performance-linked incentives (e.g., for JSY, immunization, and TB referral).

Q: Which of the following does a natural membrane condom protect against?

Conception. **Explanation:** The correct answer is **Conception**. Natural membrane condoms (also known as "lambskin" condoms) are made from the intestinal cecum of lambs. While they are effective as a mechanical barrier against sperm, they possess microscopic pores (approximately 1.5 µm in diameter). These pores are small enough to block sperm (which are about 3 µm wide), thereby preventing **conception**, but they are large enough to allow the passage of much smaller viral pathogens. **Analysis of Options:** * **Option A (Correct):** They provide effective contraception by acting as a physical barrier to sperm. * **Option B (Incorrect):** They do **not** protect against STIs, particularly viral infections like HIV, Hepatitis B, and HSV. These viruses are significantly smaller (0.1 µm) than the pores in the natural membrane. * **Option C (Incorrect):** Since they fail to provide a barrier against viral STIs, this option is false. Only latex or synthetic (polyurethane/polyisoprene) condoms protect against both. * **Option D (Incorrect):** They are an FDA-approved method for pregnancy prevention. **High-Yield Clinical Pearls for NEET-PG:** * **Latex Condoms:** The "Gold Standard" for dual protection (conception + STIs). They are degraded by oil-based lubricants (use water-based only). * **Polyurethane Condoms:** Thinner and stronger than latex; compatible with oil-based lubricants; safe for patients with latex allergies. * **Failure Rate:** The typical use failure rate for male condoms is approximately **13-18%**, while the perfect use failure rate is **2%**. * **Nonoxynol-9:** A spermicide often added to condoms; however, it may increase the risk of HIV transmission by causing vaginal/rectal mucosal irritation.

Q: The Integrated Child Development Services (ICDS) scheme covers children up to what age?

6 years. ### Explanation **Correct Answer: C. 6 years** The **Integrated Child Development Services (ICDS)** scheme, launched on October 2, 1975, is one of the world's largest programs for early childhood care and development. The primary target beneficiary group for children under this scheme is the **0–6 years** age group. This range is chosen because the first six years are considered the most critical period for brain development and nutritional foundation. **Why the other options are incorrect:** * **A & B (3 and 5 years):** While specific interventions like "Growth Monitoring" are intensive for children under 3, and school entry typically begins at 5, the legal and operational mandate of the Anganwadi center under ICDS extends until the child reaches their 6th birthday. * **D (14 years):** This age aligns with the Right to Education (RTE) Act or the National Child Labour Policy. While the **SABLA** scheme (under the ICDS umbrella) targets adolescent girls (11–18 years), the core "child" component of ICDS concludes at 6 years. **High-Yield Clinical Pearls for NEET-PG:** * **Beneficiaries:** Children (0–6 years), Pregnant women, and Lactating mothers. * **Key Services:** Supplementary nutrition, Immunization, Health check-ups, Referral services, Pre-school non-formal education (3–6 years), and Nutrition & Health education. * **The Anganwadi Worker (AWW):** The community-level frontline worker for ICDS; typically 1 AWW per 400–800 population (in plain areas). * **Nutrition Norms:** A normal child receives 500 kcal and 12-15g protein; a severely malnourished child receives 800 kcal and 20-25g protein via the "Take Home Ration" or "Hot Cooked Meal."

Q: What is the elemental iron and folic acid content of the pediatric iron-folic acid tablet supplied under the RCH program?

20 mg iron & 100 mcg folic acid. The correct answer is **A: 20 mg iron & 100 mcg folic acid**. ### **Educational Explanation** **1. Why Option A is Correct:** Under the **Anemia Mukt Bharat (AMB)** strategy (formerly under the RCH program), the dosage for children aged **5–9 years** (primary school-age) is a pink-colored, sugar-coated tablet containing **20 mg of elemental iron** and **100 mcg of folic acid**. This is administered weekly throughout the year (52 weeks). The goal is to prevent nutritional anemia during a period of rapid growth and cognitive development. **2. Analysis of Incorrect Options:** * **Option B & C (40 mg Iron):** These dosages do not align with current national guidelines for the pediatric age group. However, 45 mg of elemental iron is the dosage used for infants (6–59 months) in liquid form (bi-weekly). * **Option D (60 mg Iron):** This is the adult dosage. Under AMB, **60 mg elemental iron and 500 mcg folic acid** is the standard dose for adolescents (10–19 years), pregnant women, and lactating mothers. ### **High-Yield Clinical Pearls for NEET-PG** * **Age-wise Prophylaxis (AMB Strategy):** * **6–59 months:** 20 mg Iron + 100 mcg FA (1 ml Syrup, bi-weekly). * **5–9 years:** 20 mg Iron + 100 mcg FA (Pink Tablet, weekly). * **10–19 years:** 60 mg Iron + 500 mcg FA (Blue Tablet, weekly). * **Pregnant/Lactating:** 60 mg Iron + 500 mcg FA (Red Tablet, daily for 180 days). * **Elemental Iron Calculation:** Remember that **Ferrous Sulfate** contains 20% elemental iron, while **Ferrous Fumarate** contains 33%. * **Deworming:** Always pair iron supplementation with **Albendazole** (400 mg) twice a year (National Deworming Day) for children >2 years to ensure maximum efficacy.

Q: Non-medicated Intrauterine Devices (IUDs) are called as?

1st generation IUDs. ### Explanation **Correct Option: A (1st generation IUDs)** Intrauterine devices are classified into generations based on their composition and mechanism of action. **1st generation IUDs** are **non-medicated, inert devices** typically made of polyethylene or other polymers. They act primarily by inducing a sterile inflammatory response (foreign body reaction) in the endometrium, which is spermicidal and prevents implantation. The most classic example is the **Lippes Loop**, which is S-shaped and contains barium sulfate for radiopacity. **Analysis of Incorrect Options:** * **B. 2nd generation IUDs:** These are **medicated devices containing copper** (e.g., Cu-T 200, Cu-T 380A, Multiload 250/375). The addition of copper increases contraceptive efficacy by enhancing the spermicidal effect. * **C. 3rd generation IUDs:** These are **hormone-releasing devices** (e.g., Progestasert, LNG-20/Mirena). They release levonorgestrel, which thickens cervical mucus and thins the endometrial lining. * **D. Multi-load devices:** These are specific types of 2nd generation copper IUDs characterized by flexible side arms that reduce the risk of expulsion. **High-Yield Clinical Pearls for NEET-PG:** * **Lippes Loop:** The most common 1st generation IUD; it is no longer the first line due to higher rates of bleeding and expulsion compared to newer generations. * **Cu-T 380A (ParaGard):** The current "Gold Standard" copper IUD; it is effective for **10 years**. * **Mirena (LNG-20):** The 3rd generation IUD of choice for **Menorrhagia** (DUB) and provides protection for **5 years**. * **Mechanism of Action:** All IUDs primarily act by preventing fertilization (pre-conceptive), not as abortifacients.

Q: What is the approximate risk of mother-to-child transmission of HIV?

25%. The risk of mother-to-child transmission (MTCT) of HIV, also known as vertical transmission, occurs in the absence of any medical intervention (antiretroviral therapy, elective cesarean section, or avoidance of breastfeeding). **1. Why 25% is correct:** In a non-breastfeeding population without treatment, the transmission rate is approximately **15–25%**. In populations where breastfeeding is common (typical in many developing countries), the risk increases to **30–45%**. For examination purposes, **25%** is the standard "average" risk cited in major textbooks like Park’s Preventive and Social Medicine for a mother who is not on ART. **2. Why the other options are incorrect:** * **50% and 75%:** These values are overestimates. Even without treatment, the majority of infants born to HIV-positive mothers do not contract the virus due to the protective barrier of the placenta and maternal antibodies. * **0.6%:** This represents the risk *after* successful intervention. With highly active antiretroviral therapy (HAART), viral suppression, and proper obstetric care, the risk of transmission can be reduced to **less than 1–2%**. **3. High-Yield Clinical Pearls for NEET-PG:** * **Timing of Transmission:** Most transmissions occur during **labor and delivery** (approx. 65-70%), followed by pregnancy (in-utero) and breastfeeding. * **Prevention of Parent-to-Child Transmission (PPTCT) Protocol:** In India, the current protocol is the **"Option B+" strategy**, where all pregnant women living with HIV are started on a lifelong Triple ART regimen (Tenofovir + Lamivudine + Dolutegravir) regardless of CD4 count. * **Infant Prophylaxis:** Infants born to HIV-positive mothers receive **Syrup Nevirapine** for at least 6 weeks. * **Diagnosis in Infants:** HIV in children <18 months is diagnosed via **HIV DNA PCR** (Virological testing), not antibody tests (ELISA), due to the persistence of maternal IgG antibodies.

Q: During which period of pregnancy is iron and folic acid supplementation typically recommended?

Second trimester. **Explanation:** The correct answer is **B. Second trimester**. According to the National Iron Plus Initiative (NIPI) and the Anemia Mukt Bharat guidelines, iron and folic acid (IFA) supplementation is recommended to start from the **14th week of pregnancy** (after the first trimester is completed). **Why the Second Trimester?** 1. **Organogenesis:** During the first trimester, the fetus undergoes critical organ development. Avoiding iron supplements during this period prevents potential teratogenic risks and avoids aggravating the physiological nausea and vomiting (morning sickness) common in early pregnancy. 2. **Increased Demand:** The physiological demand for iron significantly rises in the second and third trimesters due to the expansion of maternal red cell mass and the rapid growth of the fetus and placenta. **Analysis of Incorrect Options:** * **A. First Trimester:** Supplementation is generally avoided here to prevent worsening of nausea. However, **Folic Acid (400 mcg)** is recommended *pre-conceptionally* and during the first trimester to prevent Neural Tube Defects (NTDs). * **C. Third Trimester:** While iron is continued through the third trimester, it is not the *starting* point. * **D. Puerperium:** Supplementation continues for 180 days postpartum to replenish stores, but the initiation occurs much earlier. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylactic Dose:** 100 mg elemental Iron + 500 mcg Folic Acid daily for **180 days** during pregnancy, followed by **180 days** postpartum. * **Therapeutic Dose:** If hemoglobin is <11 g/dL, the dose is doubled (two tablets daily). * **Intravenous Iron:** Ferric Carboxymaltose (FCM) is the preferred agent for moderate anemia (Hb 7–8.9 g/dL) after the first trimester. * **Counseling:** Advise patients to take iron with Vitamin C (citrus fruits) to enhance absorption and avoid tea/coffee/calcium within 2 hours of intake.

Question 1

Maternal mortality rate is calculated based on deaths occurring up to what period after delivery?

Accepted Answer

42 days after delivery

Answer

Immediately after delivery

Answer

7 days after delivery

Answer

21 days after delivery

Question 2

What is the ideal number of antenatal visits recommended?

Accepted Answer

4

Answer

8

Answer

6

Answer

10

Question 3

ASHA workers are not depot holders of which of the following?

Accepted Answer

Oral Polio Vaccine (OPV)

Answer

Oral Rehydration Salts (ORS)

Answer

Iron and Folic Acid (IFA) tablets

Answer

Contraceptives

Question 4

Which of the following does a natural membrane condom protect against?

Accepted Answer

Conception

Answer

Sexually Transmitted Infections (STIs)

Answer

Both conception and Sexually Transmitted Infections (STIs)

Answer

None of the above

Question 5

The Integrated Child Development Services (ICDS) scheme covers children up to what age?

Accepted Answer

6 years

Answer

3 years

Answer

5 years

Answer

14 years

Question 6

What is the elemental iron and folic acid content of the pediatric iron-folic acid tablet supplied under the RCH program?

Accepted Answer

20 mg iron & 100 mcg folic acid

Answer

40 mg iron & 100 mcg folic acid

Answer

40 mg iron & 50 mcg folic acid

Answer

60 mg iron & 100 mcg folic acid

Question 7

Non-medicated Intrauterine Devices (IUDs) are called as?

Accepted Answer

1st generation IUDs

Answer

2nd generation IUDs

Answer

3rd generation IUDs

Answer

Multi-load devices

Question 8

What is the approximate risk of mother-to-child transmission of HIV?

Accepted Answer

25%

Answer

50%

Answer

0.6%

Answer

75%

Question 9

A woman has shortest menstrual cycles of 26 days and longest cycle of 31 days. Calculate her unsafe period using the Rhythm method?

Accepted Answer

21st of cycle to 24th of cycle

Answer

20th of cycle to 23rd of cycle

Answer

19th of cycle to 22nd of cycle

Answer

22nd of cycle to 25th of cycle

Question 10

During which period of pregnancy is iron and folic acid supplementation typically recommended?

Accepted Answer

Second trimester

Answer

First trimester

Answer

Third trimester

Answer

Puerperium

Maternal and Child Health — MCQs

Maternal and Child Health — MCQs

On this page

Practice by Chapter

Want unlimited practice?